- Home
- SBFM vs AMIX Comparison
SBFM vs AMIX Comparison
Compare SBFM & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- AMIX
- Stock Information
- Founded
- SBFM 2006
- AMIX 2014
- Country
- SBFM United States
- AMIX United States
- Employees
- SBFM N/A
- AMIX N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- SBFM Health Care
- AMIX
- Exchange
- SBFM Nasdaq
- AMIX NYSE
- Market Cap
- SBFM 4.6M
- AMIX 4.9M
- IPO Year
- SBFM N/A
- AMIX N/A
- Fundamental
- Price
- SBFM $1.51
- AMIX $1.48
- Analyst Decision
- SBFM Strong Buy
- AMIX Strong Buy
- Analyst Count
- SBFM 1
- AMIX 1
- Target Price
- SBFM $15.00
- AMIX $5.00
- AVG Volume (30 Days)
- SBFM 104.9K
- AMIX 443.4K
- Earning Date
- SBFM 05-15-2025
- AMIX 05-29-2025
- Dividend Yield
- SBFM N/A
- AMIX N/A
- EPS Growth
- SBFM N/A
- AMIX N/A
- EPS
- SBFM N/A
- AMIX N/A
- Revenue
- SBFM $36,234,578.00
- AMIX N/A
- Revenue This Year
- SBFM $192.48
- AMIX N/A
- Revenue Next Year
- SBFM N/A
- AMIX N/A
- P/E Ratio
- SBFM N/A
- AMIX N/A
- Revenue Growth
- SBFM 35.51
- AMIX N/A
- 52 Week Low
- SBFM $1.17
- AMIX $1.30
- 52 Week High
- SBFM $11.39
- AMIX $42.40
- Technical
- Relative Strength Index (RSI)
- SBFM 54.20
- AMIX 32.78
- Support Level
- SBFM $1.37
- AMIX $1.30
- Resistance Level
- SBFM $1.56
- AMIX $1.84
- Average True Range (ATR)
- SBFM 0.08
- AMIX 0.09
- MACD
- SBFM 0.02
- AMIX -0.03
- Stochastic Oscillator
- SBFM 73.68
- AMIX 15.64
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.